Are beta2-agonists safe in patients with acute exacerbations of COPD?
作者信息
Joos Guy F
出版信息
Am J Respir Crit Care Med. 2007 Aug 15;176(4):322-3. doi: 10.1164/rccm.200704-643ED.
PMID:17675449
Abstract
摘要
相似文献
1
Are beta2-agonists safe in patients with acute exacerbations of COPD?β2 受体激动剂对慢性阻塞性肺疾病急性加重期患者是否安全？
Am J Respir Crit Care Med. 2007 Aug 15;176(4):322-3. doi: 10.1164/rccm.200704-643ED.
2
Gas exchange response to short-acting beta2-agonists in chronic obstructive pulmonary disease severe exacerbations.慢性阻塞性肺疾病严重加重期对短效β2受体激动剂的气体交换反应
Am J Respir Crit Care Med. 2007 Aug 15;176(4):350-5. doi: 10.1164/rccm.200612-1864OC. Epub 2007 Apr 12.
3
Nebulized respiratory medications: friend or foe?雾化吸入的呼吸药物：是友还是敌？
Geriatr Nurs. 2009 Jan-Feb;30(1):45-9. doi: 10.1016/j.gerinurse.2008.11.005.
4
Clinical inquiries. Are beta-2-agonists or anticholinergics more effective for treating COPD?
J Fam Pract. 2004 Jun;53(6):494-6.
5
Beta-2-agonist treatment as a potential therapy for acute inhalational lung injury.β-2激动剂治疗作为急性吸入性肺损伤的一种潜在疗法。
Crit Care Med. 2006 Jun;34(6):1841-2. doi: 10.1097/01.CCM.0000220050.03102.ED.
6
[Diagnosis and management of chronic obstructive pulmonary disease].[慢性阻塞性肺疾病的诊断与管理]
Kyobu Geka. 2007 Aug;60(9):841-8.
7
[Guidelines for the clinical management of COPD. Bronchodilatators].[慢性阻塞性肺疾病临床管理指南。支气管扩张剂]
Rev Mal Respir. 2003 Jun;20(3 Pt 2):S32-5.
8
Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPD.
Pulm Pharmacol Ther. 2003;16(4):197-201. doi: 10.1016/S1094-5539(03)00025-7.
9
[When beta-mimetic and anticholinergic agents fail in COPD. More air with theophylline].[当β受体激动剂和抗胆碱能药物对慢性阻塞性肺疾病无效时。茶碱带来更多通气]
MMW Fortschr Med. 2004 Apr 29;146(18):57.
10
[Drug therapy of airway obstruction. "Completely different for asthma and COPD"].气道阻塞的药物治疗。“哮喘和慢性阻塞性肺疾病完全不同”
MMW Fortschr Med. 2008 May 15;150(20):14, 16.
Zotero 插件